Belite Bio to discuss Q3 2024 financial results and updates on retinal disease therapies in upcoming webcast.
Read more
Immunomic Therapeutics to present RNA vaccine for Triple-negative Breast Cancer at SITC 2024.
Read more
Dizal submits NDA to FDA for sunvozertinib in treating EGFR exon20ins Non-Small Cell Lung Cancer.
Read more
TEZSPIRE shows significant efficacy in reducing nasal polyps in Phase III trial for Chronic Rhinosinusitis with Nasal Polyps.
Read more
HUYABIO's HBI-8000 and nivolumab combination shows promise in Phase 2 trial for advanced Melanoma.
Read more
AbbVie's emraclidine fails Phase II trials for Schizophrenia, boosting Bristol Myers Squibb's competitive position.
Read more
Coloplast expands Executive Leadership Team to drive growth in Chronic Care, Voice & Respiratory Care, and Interventional Urology.
Read more
EpiBone raises funds to advance global clinical trials in skeletal reconstruction using regenerative medicine.
Read more
Stand Up To Cancer and Johnson & Johnson collaborate on targeted therapies for AL Amyloidosis linked to blood cancers.
Read more
Cofactor Genomics' OncoPrism-HNSCC test shows improved prediction of immunotherapy response in Head and Neck Squamous Cell Carcinoma.
Read more
Synthekine's STK-012 shows promising results in Phase 1a trial for advanced solid tumors, enhancing T cell activation with reduced IL-2 toxicity.
Read more
NGS services market projected to reach USD 18.35 billion by 2031, driven by precision medicine and technological advancements.
Read more
Century Therapeutics expands CNTY-101 trials to include systemic sclerosis and idiopathic inflammatory myopathy, showing 83% ORR in B-cell lymphomas.
Read more
Palleon Pharmaceuticals' E-602 shows promise in Phase 1/2 trial for PD-1-resistant solid tumors.
Read more
Veravas and Phanes Biotech partner to develop a blood-based test for early Alzheimer's Disease detection.
Read more
Anixa Biosciences reports positive Phase 1 results for breast cancer vaccine, plans Phase 2 trial in 2025.
Read more
Infinitopes to present cancer vaccine ITOP1 Phase I/IIa trial data at SITC 2024 for Oesophageal Neoplasms.
Read more
J INTS BIO launches AI alliance to enhance precision oncology for Lung Neoplasms.
Read more
Chung-Ang University develops a non-invasive biosensor for early detection of Kidney Diseases using urine-based SDMA measurement.
Read more
Radella's MD-18 shows safety and metabolic benefits in Phase 1a trial for Obesity and Type 2 Diabetes.
Read more
Neumora and J&J's Phase III trials may define the market for κ-opioid receptor antagonists in Major Depressive Disorder.
Read more
FDA approves Hympavzi, a novel non-factor treatment for Hemophilia A and B, reducing bleeding episodes significantly.
Read more
AlloVir and Kalaris merge to advance TH103 for neovascular age-related macular degeneration and other retinal diseases.
Read more
Harbinger Health partners with Memorial Sloan Kettering to advance early cancer detection through blood-based tests.
Read more
FDA approves first CLDN18.2 monoclonal antibody and expands labels for five therapies.
Read more
